Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Sungen Biomedical Technology Co., Ltd

Clinical trials sponsored by Beijing Sungen Biomedical Technology Co., Ltd, explained in plain language.

Not yet recruiting 1 Completed 2

Experimental drug aims to save heart muscle during heart attack

Disease control Not yet recruiting

This study is testing whether a new, single-dose injection called SGC001 can help reduce permanent heart damage in people who are having a major heart attack affecting the front of the heart. The drug is given during emergency treatment to open a blocked artery. Researchers will …

Phase: PHASE2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC